Low-dose heparin use and the patency of peripheral IV catheters in children: A systematic review

Pediatrics

Volumn 131, Issue 3, 2013, Pages

  Kumar, Manoj ^a,d   Vandermeer, Ben ^b   Bassler, Dirk ^c   Mansoor, Nadia ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Heparin; Infusion failure; Patency; Phlebitis; Systematic review

Indexed keywords

HEPARIN; PLACEBO;

BRAIN HEMORRHAGE; CONSENSUS; CONTINUOUS INFUSION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTRAVENOUS CATHETER; LOW DRUG DOSE; MULTICENTER STUDY (TOPIC); NEWBORN SEPSIS; PERIPHERAL INTRAVENOUS CATHETER; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR PATENCY;

CATHETERIZATION, PERIPHERAL; CHILD; DRUG ADMINISTRATION SCHEDULE; HEPARIN; HUMANS; INFUSIONS, INTRAVENOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASCULAR PATENCY;

EID: 84874584428     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-2403     Document Type: Review

References (23)

1. Barrington KJ. Umbilical artery catheters in the newborn: effects of heparin. Cochrane Database Syst Rev. 2000;(2): CD000507
2. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a metaanalysis of randomized controlled trials. Chest. 1998;113(1):165-171
3. Shah PS, Shah VS. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Syst Rev. 2008;(2):CD002772
4. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials. BMJ. 1998;316(7136):969-975
5. Shah PS, Ng E, Sinha AK. Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database Syst Rev. 2005;(4):CD002774
6. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org. Accessed August 2, 2012
7. Alpan G, Eyal F, Springer C, Glick B, Goder K, Armon J. Heparinization of alimentation solutions administered through peripheral veins in premature infants: a controlled study. Pediatrics. 1984;74(3):375-378
8. Klenner AF, Fusch C, Rakow A, et al. Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial. J Pediatr. 2003;143(6):741-745
9. Moclair A, Bates I. The efficacy of heparin in maintaining peripheral infusions in neonates. Eur J Pediatr. 1995;154(7):567-570
10. Arnts IJ, Heijnen JA, Wilbers HT, van der Wilt GJ, Groenewoud JM, Liem KD. Effectiveness of heparin solution versus normal saline in maintaining patency of intravenous locks in neonates: a double blind randomized controlled study. J Adv Nurs. 2011;67(12):2677-2685
11. Beecroft PC, Bossert E, Chung K, et al. Intravenous lock patency in children: dilute heparin versus saline. J Pediatr Pharm Pract. 1997;2(4):211-223
12. Brown K, Tay-Uyboco JS, McMillan DD. Heparin is not required for peripheral intravenous locks in neonates. Paediatr Child Health (Oxford). 1999;4(1):39-42
13. Heilskov J, Kleiber C, Johnson K, Miller J. A randomized trial of heparin and saline for maintaining intravenous locks in neonates. J Soc Pediatr Nurs. 1998;3(3):111-116
14. Kleiber C, Hanrahan K, Fagan CL, Zittergruen MA. Heparin vs. saline for peripheral i.v. locks in children. Pediatr Nurs. 1993;19(4): 405-409, 376
15. Kotter RW. Heparin vs saline for intermittent intravenous device maintenance in neonates. Neonatal Netw. 1996;15(6): 43-47
16. McMullen A, Fioravanti ID, Pollack V, Rideout K, Sciera M. Heparinized saline or normal saline as a flush solution in intermittent intravenous lines in infants and children. MCN Am J Matern Child Nurs. 1993;18(2): 78-85
17. Mok E, Kwong TK, Chan MF. A randomized controlled trial for maintaining peripheral intravenous lock in children. Int J Nurs Pract. 2007;13(1):33-45
18. Nelson TJ, Graves SM. 0.9% sodium chloride injection with and without heparin for maintaining peripheral indwelling intermittentinfusion devices in infants. Am J Health Syst Pharm. 1998;55(6):570-573
19. Schultz AA, Drew D, Hewitt H. Comparison of normal saline and heparinized saline for patency of IV locks in neonates. Appl Nurs Res. 2002;15(1):28-34
20. Ioannidis JP, Patsopoulos NA, Rothstein HR. Reasons or excuses for avoiding metaanalysis in forest plots. BMJ. 2008;336 (7658):1413-1415
21. Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care. 2003;6(3):319-325
22. Maki DG, Ringer M. Risk factors for infusionrelated phlebitis with small peripheral venous catheters: a randomized controlled trial. Ann Intern Med. 1991;114(10):845-854
23. Matlow AG, Kitai I, Kirpalani H, et al. A randomized trial of 72-versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy. Infect Control Hosp Epidemiol. 1999;20(7):487-493